Ads
related to: apixaban and verapamil interaction checker free- XARELTO® Dosing
View Dosing Guide & Prescribing
Info Across 11 Indications
- XARELTO® Starter Pack
Use This Starter Pack To Help
Initiate Treatment After Diagnosis
- XARELTO® Cost Info
How Much Will I Need to Pay?
View XARELTO® Savings Information
- Important Safety Info
View Important Safety Information
For XARELTO® Tablets
- XARELTO® Dosing
qbd.creative-diagnostics.com has been visited by 10K+ users in the past month
singlecare.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
The p-methoxy group of apixaban connects to S1 pocket of FXa but does not appear to have any interaction with any residues in this region of FXa. The pyrazole N-2 nitrogen atom of apixaban interacts with Gln-192 and the carbonyl oxygen interacts with Gly-216. The phenyl lactam group of apixaban is positioned between Tyr-99 and Phe-174 and due ...
Compared to warfarin it has fewer interactions with other medications. [13] It is a direct factor Xa inhibitor. [9] In 2007, Pfizer and Bristol-Myers Squibb began the development of apixaban as an anticoagulant. [14] Apixaban was approved for medical use in the European Union in May 2011, and in the United States in December 2012.
Skeletal formula of verapamil. Phenylalkylamine calcium channel blockers are relatively selective for myocardium, reduce myocardial oxygen demand and reverse coronary vasospasm, and are often used to treat angina.
Verapamil is a class-IV antiarrhythmic and more effective than digoxin in controlling ventricular rate. [19] Verapamil is not listed as a first line antihypertensive agent by the guidelines provided by JAMA in JNC-8. [20] However, it may be used to treat hypertension if patient has co-morbid atrial fibrillation or other types of arrhythmia. [17 ...
Compared with certain other L-type calcium channel blockers (for example those of the phenylalkylamine class such as verapamil) that have significant action at the heart, the dihydropyridine calcium channel blockers lower blood pressure mainly by relaxing the smooth muscle of the blood vessel walls. [3]
A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, increasing the risk of heart attacks and strokes, a new study in mice indicates.